Oncologie

, Volume 11, Issue 4, pp 211–217 | Cite as

Comment dépister la dénutrition au cours du cancer?

Synthèse / Review Article

Résumé

Le dépistage du risque nutritionnel passe par la mesure de la perte de poids du patient. Cette détection ne doit pas être une fin en soi mais entraîner une évaluation nutritionnelle. Celle-ci, effectuée par un professionnel en nutrition, doit comporter une mesure de l’activité inflammatoire et une évaluation de la balance énergétique. Pour être complète, elle doit comporter une analyse de la composition corporelle et des conséquences fonctionnelles sur la qualité de vie, la force musculaire ou bien les fonctions immunitaires. La fréquence de plus en plus élevée des patients obèses et de l’incidence du cancer au cours de la surcharge pondérale pose le problème de la détection précoce de la diminution de la masse musculaire dans ces conditions de surpoids.

Mots clés

Détection Évaluation Risque nutritionnel Composition corporelle 

What are the nutrition screening tools in patients with cancer?

Abstract

Weight loss is the key screening element for malnutrition, and if present must be followed-up by a complete nutritional assessment. This assessment, made by a professional in nutrition, should include an evaluation of energy balance as well as a measurement of inflammatory activity. To be complete, it must also measure body composition. An analysis of the quality of life, the muscular strength and the immune functions reveals the level of functional impairment associated with the nutritional status. The increasing frequency of obese patients and the high incidence of cancer associated with weight excess point to the problem of early detection of decrease in muscle mass.

Keywords

Screening tools Assessment Nutritional risk Body composition 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Références

  1. 1.
    Amaral TF, Antunes A, Cabral S, et al. (2008) An evaluation of three nutritional screening tools in a portuguese oncology centre. J Hum Nutr Diet 21: 575–583PubMedCrossRefGoogle Scholar
  2. 2.
    Andreyev HJN, Norman AR, Oates J, et al. (1998) Why do patients with weight loss have a worse outcome when undergoing chemotherapy for gastrointestinal malignancies. Eur J Cancer 34: 503–509PubMedCrossRefGoogle Scholar
  3. 3.
    Dewys WD, Begg C, Lavin PT, et al. (1980) Prognostic effect of weight loss prior to chemotherapy in cancer patients. Am J Med 69: 491–497PubMedCrossRefGoogle Scholar
  4. 4.
    Elia M, Zellipour L, Stratton RJ (2005) To screen or not to screen for adult malnutrition? Clin Nutr 24: 867–884PubMedCrossRefGoogle Scholar
  5. 5.
    Evans WJ, Morley JE, Argilès J, et al. (2008) Cachexia: a new definition. Clin Nutr 27: 793–799PubMedCrossRefGoogle Scholar
  6. 6.
    Fearon KC, Voss AC, Hustead DS, et al. (2006) Definition of cancer cachexia: effect of weight loss, reduce food intake, and systemic inflammation on functional status and prognosis. Am J Clin Nutr 83: 1345–1350PubMedGoogle Scholar
  7. 7.
    Geisler JP, Linnemeier GC, Thomas AJ, et al. (2007) Nutritional assessment using prealbumin as an objective criterion to determine whom should not undergo primary radical cytoreductive surgery for ovarian cancer. Gynecol Oncol 106: 128–131PubMedCrossRefGoogle Scholar
  8. 8.
    Green SM, Watson R (2006) Nutritional screening and assessment tools for use by nurses: literature review. J Adv Nurs 54: 477–490PubMedCrossRefGoogle Scholar
  9. 9.
    Gupta D, Lis CG, Granick J, et al. (2006) Malnutrition was associated with poor quality of life in colorectal cancer: a retrospective analysis. J Clin Epidemiol 59: 704–709PubMedCrossRefGoogle Scholar
  10. 10.
    Huhmann MB, Cunningham RS (2005) Importance of nutritional screening in treatment of cancer-related weight loss. Lancet Oncol 6: 334–343PubMedCrossRefGoogle Scholar
  11. 11.
    Isenring E, Bauer J, Capra S (2003) The scored patient-generated subjective global assessment (PG-SGA) and its association with quality of life in ambulatoty patients receiving radiotherapy. Eur J Clin Nutr 57: 305–309PubMedCrossRefGoogle Scholar
  12. 12.
    Iversen PO, Ukrainchenko E, Afanayev B, et al. (2008) Impaired nutritional status during chemotherapy in russian and norvwegian cohorts with acute myeloid leukemia. Leu Lym 49: 1916–1924CrossRefGoogle Scholar
  13. 13.
    Jones JM (2002) The methodology of nutritional screening and assessment tool. J Hum Nutr Dietet 15: 59–71CrossRefGoogle Scholar
  14. 14.
    Kondrup J, Allison SP, Elia M, et al. (2003) ESPEN guidelines for nutrition screening. Clin Nutr 22: 415–421PubMedCrossRefGoogle Scholar
  15. 15.
    Kondrup J, Johansen N, Plum LM, et al. (2002) Incidence of nutritional risk and causes of inadequate nutritional care in hospitals. Clin Nutr 21: 461–468PubMedCrossRefGoogle Scholar
  16. 16.
    Laky B, Janda M, Cleghorn G, et al. (2008) Comparaison of different nutritional assessments and body-composition measurements in detecting malnutrition among gynecologic cancer patients. Am J Clin Nutr 87: 1678–1685PubMedGoogle Scholar
  17. 17.
    Lochs H, Allison SP, Meier R, et al. (2006) Introductory to the ESPEN guidelines on enteral nutrition: terminology, definitions and general topics. Clin Nutr 25: 180–186PubMedCrossRefGoogle Scholar
  18. 18.
    McMillan DC, Watson WS, O’Gorman P, et al. (2001) Albumin concentrations are primarily determined by body cell mass and the sys-temic inflammatory response in cancer pat-ients with weight loss. Nutr cancer 39: 210–213PubMedCrossRefGoogle Scholar
  19. 19.
    Mourtzakis M, Prado CMM, Lieffers JR, et al. (2008) A pratical and precise approach to quantification of body composition in cancer patients using computed tomography images acquired during routine care. Appl Physiol Nutr Metabol 33: 997–1006CrossRefGoogle Scholar
  20. 20.
    Pham NV, Cox-Reijven PLM, Wodzid WKH, et al. (2006) SGA and measures for muscle mass and strength in surgical vietnamese patients. Nutrition 23: 283–291CrossRefGoogle Scholar
  21. 21.
    Prado CMM, Baracos VE, McCargar LJ, et al. (2007) Body composition as an independent determinant of 5-fluorouracilbased chemotherapy toxicity. Clin Cancer Res 13: 3264–3268PubMedCrossRefGoogle Scholar
  22. 22.
    Prado CMM, Lieffers JR, McCargar LJ, et al. (2008) Prevalence and clinical implications of sarcopenic obesity in patients with solid tumors of the respiratory and gastrointestinal tracts: a population based study. Lancet Oncol 9: 629–635PubMedCrossRefGoogle Scholar
  23. 23.
    Soeters PB, Reijven PLM, van Bokhorstde van der Shueren MA, et al. (2008) A rational approach to nutritional assessment. Clin Nutr 27: 706–716PubMedCrossRefGoogle Scholar
  24. 24.
    Spiro A, Baldwin C, Patterson A, et al. (2006) The views and practice of oncologists towards nutritional support in patients receiving chemotherapy. Br J Cancer 95: 431–434PubMedCrossRefGoogle Scholar
  25. 25.
    Stentholm S, Harris TB, Rantanen T, et al. (2008) Sarcopenic obesity: definition, cause and consequences. Curr Opin Clin Nutr Metab Care 11: 693–700CrossRefGoogle Scholar
  26. 26.
    Veterans Affairs Total Parenteral Nutrition Cooperative Study Group (1991) Perioperative total parenteral nutrition in surgical patients. N Engl J Med 325: 525–532CrossRefGoogle Scholar

Copyright information

© Springer Verlag France 2009

Authors and Affiliations

  1. 1.Service des urgences, comitéliaison alimentation-nutritioninstitut Gustave-RoussyVillejuif cedexFrance
  2. 2.Department of OncologyUniversity of Alberta, Cross Cancer InstituteEdmontonCanada

Personalised recommendations